Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 4

2(40.0%)

N/A

2(40.0%)

Phase 2

1(20.0%)

5Total

Phase 4(2)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06839469Recruiting

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Role: collaborator

NCT06648863Completed

Bahir Dar Child Development Study, Ethiopia

Role: collaborator

NCT07071324Not ApplicableRecruiting

CF Wellness Program

Role: collaborator

NCT07300956Phase 4Not Yet Recruiting

Treating Young Children With Attention Deficit Hyperactivity Disorder

Role: collaborator

NCT06992544Not ApplicableActive Not Recruiting

Trial of Pistachio Consumption in Older Adults

Role: collaborator

NCT05747534Phase 2Recruiting

AT1001 for the Treatment of Long COVID

Role: collaborator

NCT04219280Phase 4Recruiting

Evaluating Treatment of ADHD in Children with Down Syndrome

Role: collaborator

NCT04725422Recruiting

CHronic Nonbacterial Osteomyelitis International Registry

Role: collaborator

All 8 trials loaded